Catalyst Pharmaceuticals (CPRX) Work In Process (2023 - 2026)

Catalyst Pharmaceuticals (CPRX) has 4 years of Work In Process data on file, last reported at $2.8 million in Q1 2026.

• Quarterly Work In Process fell 34.42% year-over-year to $2.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.8 million (down 34.42% YoY) and the FY2025 annual result came in at $3.9 million, up 12.37% from the prior year.
• Work In Process retreated to $2.8 million in Q1 2026, from $3.9 million in the prior quarter.
• In the past five years, Work In Process ranged from a high of $5.3 million in Q2 2025 to a low of $2.8 million in Q1 2026.
• A 4-year average of $4.1 million and a median of $4.0 million in 2024 frame the typical range for Work In Process.
• Annual changes were most pronounced in 2025 — Work In Process surged 32.89% — and 2026, when it sank 34.42%.
• Tracing CPRX's Work In Process over 4 years: stood at $4.6 million in 2023, then retreated by 24.67% to $3.4 million in 2024, then climbed by 12.37% to $3.9 million in 2025, then declined by 28.44% to $2.8 million in 2026.
• The last three Work In Process figures came in at $2.8 million (Q1 2026), $3.9 million (Q4 2025), and $4.6 million (Q3 2025), per Business Quant data.